Arcadia Biosciences Stock Market Value
| RKDA Stock | USD 2.76 0.02 0.73% |
| Symbol | Arcadia |
Arcadia Biosciences Price To Book Ratio
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Earnings Share (6.77) | Revenue Per Share 3.802 | Quarterly Revenue Growth (0.04) | Return On Assets (0.39) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Arcadia Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arcadia Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arcadia Biosciences.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Arcadia Biosciences on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Arcadia Biosciences or generate 0.0% return on investment in Arcadia Biosciences over 30 days. Arcadia Biosciences is related to or competes with Better Choice, Stryve Foods, Bit Origin, Farmmi, Laird Superfood, Planet Green, and Seneca Foods. Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States More
Arcadia Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arcadia Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arcadia Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.43 | |||
| Information Ratio | 0.0101 | |||
| Maximum Drawdown | 49.4 | |||
| Value At Risk | (12.63) | |||
| Potential Upside | 10.64 |
Arcadia Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcadia Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arcadia Biosciences' standard deviation. In reality, there are many statistical measures that can use Arcadia Biosciences historical prices to predict the future Arcadia Biosciences' volatility.| Risk Adjusted Performance | 0.0311 | |||
| Jensen Alpha | 0.3913 | |||
| Total Risk Alpha | (0.89) | |||
| Sortino Ratio | 0.0094 | |||
| Treynor Ratio | (0.11) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcadia Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arcadia Biosciences Backtested Returns
At this point, Arcadia Biosciences is dangerous. Arcadia Biosciences secures Sharpe Ratio (or Efficiency) of 0.0205, which signifies that the company had a 0.0205% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Arcadia Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Arcadia Biosciences' risk adjusted performance of 0.0311, and Mean Deviation of 4.47 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%. Arcadia Biosciences has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -1.67, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Arcadia Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Arcadia Biosciences is expected to outperform it. Arcadia Biosciences right now shows a risk of 6.84%. Please confirm Arcadia Biosciences maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if Arcadia Biosciences will be following its price patterns.
Auto-correlation | 0.68 |
Good predictability
Arcadia Biosciences has good predictability. Overlapping area represents the amount of predictability between Arcadia Biosciences time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arcadia Biosciences price movement. The serial correlation of 0.68 indicates that around 68.0% of current Arcadia Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.35 |
Arcadia Biosciences lagged returns against current returns
Autocorrelation, which is Arcadia Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arcadia Biosciences' stock expected returns. We can calculate the autocorrelation of Arcadia Biosciences returns to help us make a trade decision. For example, suppose you find that Arcadia Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arcadia Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arcadia Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arcadia Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arcadia Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Arcadia Biosciences Lagged Returns
When evaluating Arcadia Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arcadia Biosciences stock have on its future price. Arcadia Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arcadia Biosciences autocorrelation shows the relationship between Arcadia Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Arcadia Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:Check out Arcadia Biosciences Correlation, Arcadia Biosciences Volatility and Arcadia Biosciences Alpha and Beta module to complement your research on Arcadia Biosciences. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Arcadia Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.